| Literature DB >> 6631441 |
R E Jones, J R Heron, D H Foster, R S Snelgar, R J Mason.
Abstract
4-Aminopyridine (4-AP) was administered to two groups of patients with multiple sclerosis (MS). The first group consisted of 5 patients with labile visual symptoms, 2 of whom had arcuate scotomata. 4-AP improved visual performance of most patients in this group and reduced the size of scotomata. The second group consisted of 5 patients with the spinal form of MS who were in a stable state; in this group 4-AP had little effect clinically or on tests of visual function.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6631441 DOI： 10.1016/0022-510x(83)90145-4
Source DB: PubMed Journal: J Neurol Sci ISSN： 0022-510X Impact factor: 3.181